WEBULL
News
PGEN
4.615
+1.21%
0.055
Weekly Report: what happened at PGEN last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at PGEN last week (0126-0130)?
Weekly Report · 02/02 10:36
Precigen (PGEN) Is Down 5.7% After Consensus Backs PAPZIMEOS As New First-Line RRP Therapy
Simply Wall St · 01/30 23:38
Weekly Report: what happened at PGEN last week (0119-0123)?
Weekly Report · 01/26 10:36
Assessing Precigen (PGEN) Valuation After PAPZIMEOS Becomes Preferred First Line RRP Treatment
Simply Wall St · 01/24 15:35
Why Precigen (PGEN) Is Up 5.3% After PAPZIMEOS Becomes First-Line RRP Standard of Care – And What's Next
Simply Wall St · 01/21 16:19
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
PR Newswire · 01/20 13:05
Weekly Report: what happened at PGEN last week (0112-0116)?
Weekly Report · 01/19 10:44
Assessing Precigen (PGEN) Valuation After PAPZIMEOS Commercial Momentum And EMA Milestone
Simply Wall St · 01/15 06:30
Is PGEN’s PAPZIMEOS Exclusivity Quietly Redefining Its Competitive Moat in Rare Disease Therapy?
Simply Wall St · 01/14 03:31
Precigen Provides Update On Therapy For Recurrent Respiratory Papillomatosis, To Present Data At J.P. Morgan Healthcare Conference
Benzinga · 01/12 13:17
Precigen Highlights PAPZIMEOS Launch Success at J.P. Morgan Healthcare Conference
Reuters · 01/12 13:04
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
PR Newswire · 01/12 13:00
Weekly Report: what happened at PGEN last week (0105-0109)?
Weekly Report · 01/12 10:42
Precigen, Inc. (NASDAQ:PGEN): Are Analysts Optimistic?
Simply Wall St · 01/08 12:29
Weekly Report: what happened at PGEN last week (1229-0102)?
Weekly Report · 01/05 10:36
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga · 12/29/2025 17:33
DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday
Benzinga · 12/29/2025 15:30
Weekly Report: what happened at PGEN last week (1222-1226)?
Weekly Report · 12/29/2025 10:34
Director and 10% Owner Randal J. Kirk Reports Sale of Precigen Inc. Common Shares
Reuters · 12/23/2025 01:49
More
Webull provides a variety of real-time PGEN stock news. You can receive the latest news about Precigen Inc through multiple platforms. This information may help you make smarter investment decisions.
About PGEN
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.